• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类冠状病毒的结构蛋白:它们有何不同之处?

Structural proteins of human coronaviruses: what makes them different?

作者信息

Minigulov Nail, Boranbayev Kuandyk, Bekbossynova Ayaulym, Gadilgereyeva Bakhytgul, Filchakova Olena

机构信息

Biology Department, School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.

出版信息

Front Cell Infect Microbiol. 2024 Dec 6;14:1458383. doi: 10.3389/fcimb.2024.1458383. eCollection 2024.

DOI:10.3389/fcimb.2024.1458383
PMID:39711780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11659265/
Abstract

Following COVID-19 outbreak with its unprecedented effect on the entire world, the interest to the coronaviruses increased. The causative agent of the COVID-19, severe acute respiratory syndrome coronavirus - 2 (SARS-CoV-2) is one of seven coronaviruses that is pathogenic to humans. Others include SARS-CoV, MERS-CoV, HCoV-HKU1, HCoV-OC43, HCoV-NL63 and HCoV-229E. The viruses differ in their pathogenicity. SARS-CoV, MERS-CoV, and SARS-CoV-2 are capable to spread rapidly and cause epidemic, while HCoV-HKU1, HCoV-OC43, HCoV-NL63 and HCoV-229E cause mild respiratory disease. The difference in the viral behavior is due to structural and functional differences. All seven human coronaviruses possess four structural proteins: spike, envelope, membrane, and nucleocapsid. Spike protein with its receptor binding domain is crucial for the entry to the host cell, where different receptors on the host cell are recruited by different viruses. Envelope protein plays important role in viral assembly, and following cellular entry, contributes to immune response. Membrane protein is an abundant viral protein, contributing to the assembly and pathogenicity of the virus. Nucleocapsid protein encompasses the viral RNA into ribonucleocapsid, playing important role in viral replication. The present review provides detailed summary of structural and functional characteristics of structural proteins from seven human coronaviruses, and could serve as a practical reference when pathogenic human coronaviruses are compared, and novel treatments are proposed.

摘要

在新型冠状病毒肺炎(COVID-19)疫情爆发并对全球产生前所未有的影响之后,人们对冠状病毒的关注度有所增加。COVID-19的病原体严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是七种可致人类致病的冠状病毒之一。其他包括严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)、人冠状病毒HKU1(HCoV-HKU1)、人冠状病毒OC43(HCoV-OC43)、人冠状病毒NL63(HCoV-NL63)和人冠状病毒229E(HCoV-229E)。这些病毒的致病性各不相同。SARS-CoV、MERS-CoV和SARS-CoV-2能够迅速传播并引发疫情,而HCoV-HKU1、HCoV-OC43、HCoV-NL63和HCoV-229E则引起轻度呼吸道疾病。病毒行为的差异归因于结构和功能的不同。所有七种人类冠状病毒都拥有四种结构蛋白:刺突蛋白、包膜蛋白、膜蛋白和核衣壳蛋白。带有受体结合域的刺突蛋白对于进入宿主细胞至关重要,不同的病毒会募集宿主细胞上不同的受体。包膜蛋白在病毒组装中起重要作用,并且在进入细胞后,有助于免疫反应。膜蛋白是一种丰富的病毒蛋白,有助于病毒的组装和致病性。核衣壳蛋白将病毒RNA包裹成核糖核衣壳,在病毒复制中起重要作用。本综述详细总结了七种人类冠状病毒结构蛋白的结构和功能特征,在比较致病性人类冠状病毒和提出新的治疗方法时可作为实用参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/2004d9a36177/fcimb-14-1458383-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/85837073d5f8/fcimb-14-1458383-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/107acb40dea2/fcimb-14-1458383-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/de538421bb55/fcimb-14-1458383-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/44bad188884a/fcimb-14-1458383-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/9aeab2406edd/fcimb-14-1458383-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/b650cc485354/fcimb-14-1458383-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/404df6dd7f35/fcimb-14-1458383-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/7c14260c834b/fcimb-14-1458383-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/2004d9a36177/fcimb-14-1458383-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/85837073d5f8/fcimb-14-1458383-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/107acb40dea2/fcimb-14-1458383-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/de538421bb55/fcimb-14-1458383-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/44bad188884a/fcimb-14-1458383-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/9aeab2406edd/fcimb-14-1458383-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/b650cc485354/fcimb-14-1458383-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/404df6dd7f35/fcimb-14-1458383-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/7c14260c834b/fcimb-14-1458383-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/2004d9a36177/fcimb-14-1458383-g009.jpg

相似文献

1
Structural proteins of human coronaviruses: what makes them different?人类冠状病毒的结构蛋白:它们有何不同之处?
Front Cell Infect Microbiol. 2024 Dec 6;14:1458383. doi: 10.3389/fcimb.2024.1458383. eCollection 2024.
2
A Comparison of Conserved Features in the Human Coronavirus Family Shows That Studies of Viruses Less Pathogenic than SARS-CoV-2, Such as HCoV-OC43, Are Good Model Systems for Elucidating Basic Mechanisms of Infection and Replication in Standard Laboratories.人类冠状病毒家族保守特征的比较表明,对致病性低于SARS-CoV-2的病毒(如HCoV-OC43)的研究是在标准实验室中阐明感染和复制基本机制的良好模型系统。
Viruses. 2025 Feb 13;17(2):256. doi: 10.3390/v17020256.
3
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.HTCC 作为 SARS-CoV-2 和 MERS-CoV 的聚合抑制剂。
J Virol. 2021 Jan 28;95(4). doi: 10.1128/JVI.01622-20.
4
Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics.季节性人类冠状病毒 OC43、229E 和 NL63 诱导细胞表面进入受体的调制,并显示宿主细胞特异性的病毒复制动力学。
Microbiol Spectr. 2024 Jul 2;12(7):e0422023. doi: 10.1128/spectrum.04220-23. Epub 2024 Jun 12.
5
Properties of Coronavirus and SARS-CoV-2.冠状病毒及新型冠状病毒(SARS-CoV-2)的特性
Malays J Pathol. 2020 Apr;42(1):3-11.
6
Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes.携带季节性人类冠状病毒NL63、229E和HKU1刺突的慢病毒假病毒刺突S1/S2加工及进入途径的表征
Microbiol Spectr. 2025 Mar 4;13(3):e0280824. doi: 10.1128/spectrum.02808-24. Epub 2025 Jan 28.
7
Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses.用于定量检测交叉中和抗体反应的所有循环人类冠状病毒的冠状病毒假型。
Viruses. 2021 Aug 10;13(8):1579. doi: 10.3390/v13081579.
8
An overview on the seven pathogenic human coronaviruses.七种人类致病冠状病毒概述。
Rev Med Virol. 2022 Mar;32(2):e2282. doi: 10.1002/rmv.2282. Epub 2021 Aug 2.
9
Coronaviruses and SARS-COV-2.冠状病毒和 SARS-COV-2。
Turk J Med Sci. 2020 Apr 21;50(SI-1):549-556. doi: 10.3906/sag-2004-127.
10
Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.确定控制IFITM蛋白对人冠状病毒进入的限制与增强活性的残基。
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.01535-17. Print 2018 Mar 15.

引用本文的文献

1
Spike proteins of coronaviruses activate mast cells for degranulation via stimulating Src/PI3K/AKT/Ca intracellular signaling cascade.冠状病毒的刺突蛋白通过刺激Src/PI3K/AKT/Ca细胞内信号级联反应激活肥大细胞进行脱颗粒。
J Virol. 2025 May 20;99(5):e0007825. doi: 10.1128/jvi.00078-25. Epub 2025 Apr 30.

本文引用的文献

1
Oligomeric State and Drug Binding of the SARS-CoV-2 Envelope Protein Are Sensitive to the Ectodomain.SARS-CoV-2 包膜蛋白的寡聚状态和药物结合对其胞外域敏感。
J Am Chem Soc. 2024 Sep 4;146(35):24537-24552. doi: 10.1021/jacs.4c07686. Epub 2024 Aug 21.
2
SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.SARS-CoV-2 通过抑制 LDHB 利用 Spike 糖蛋白来控制宿主的无氧代谢。
Int J Biol Macromol. 2024 Oct;278(Pt 3):134638. doi: 10.1016/j.ijbiomac.2024.134638. Epub 2024 Aug 13.
3
SARS-CoV-2 spike protein acts as a β-adrenergic receptor agonist: A potential mechanism for cardiac sequelae of long COVID.
SARS-CoV-2 刺突蛋白作为一种β-肾上腺素能受体激动剂:长新冠心脏后遗症的潜在机制。
J Intern Med. 2024 Sep;296(3):291-297. doi: 10.1111/joim.20000. Epub 2024 Jul 29.
4
SARS-CoV-2 envelope protein regulates innate immune tolerance.严重急性呼吸综合征冠状病毒2包膜蛋白调节先天性免疫耐受。
iScience. 2024 May 15;27(6):109975. doi: 10.1016/j.isci.2024.109975. eCollection 2024 Jun 21.
5
Design, Synthesis, and Structure-Activity Relationships of Novel Peptide Derivatives of the Severe Acute Respiratory Syndrome-Coronavirus-2 Spike-Protein that Potently Inhibit Nicotinic Acetylcholine Receptors.新型严重急性呼吸综合征冠状病毒 2 刺突蛋白肽衍生物的设计、合成及构效关系研究,该衍生物能有效抑制烟碱型乙酰胆碱受体。
J Med Chem. 2024 Jun 13;67(11):9587-9598. doi: 10.1021/acs.jmedchem.4c00735. Epub 2024 May 30.
6
Mechanistic insights into SARS-CoV-2 spike protein induction of the chemokine CXCL10.解析 SARS-CoV-2 刺突蛋白诱导趋化因子 CXCL10 的机制研究
Sci Rep. 2024 May 16;14(1):11179. doi: 10.1038/s41598-024-61906-6.
7
The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells.SARS-CoV-2 刺突蛋白在宫颈癌细胞生长中的作用。
Anticancer Res. 2024 May;44(5):1807-1815. doi: 10.21873/anticanres.16982.
8
The seasonal behaviour of COVID-19 and its galectin-like culprit of the viral spike.新冠病毒(COVID-19)的季节性行为及其病毒刺突中类似半乳糖凝集素的致病因素。
Methods Microbiol. 2022;50:27-81. doi: 10.1016/bs.mim.2021.10.002. Epub 2021 Nov 15.
9
SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand.泰国南部边境省份出现带有刺突蛋白突变 F306L 的 SARS-CoV-2 变异株。
Sci Rep. 2024 Apr 2;14(1):7729. doi: 10.1038/s41598-024-56646-6.
10
SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl concentration.SARS-CoV-2 包膜蛋白通过增加细胞内 Cl-浓度损害气道上皮屏障功能并加剧气道炎症。
Signal Transduct Target Ther. 2024 Mar 25;9(1):74. doi: 10.1038/s41392-024-01753-z.